[FIBRINOLYSIS AND ANTIFIBRINOLYTIC THERAPY IN UROLOGIC OPERATIONS. EXAMINATIONS USING A NEW METHOD FOR MEASURING FIBRINOLYSIS].
D000614:Aminocaproates; D015119:Aminocaproic Acid; D000933:Antifibrinolytic Agents; D007611:Aprotinin; D004358:Drug Therapy; D005337:Fibrin; D005340:Fibrinogen; D005341:Fibrinolysin; D005342:Fibrinolysis; D006801:Humans; D008297:Male; D011468:Prostatectomy; D011470:Prostatic Hyperplasia; D011471:Prostatic Neoplasms; D013514:Surgical Procedures, Operative; D014361:Trypsin Inhibitors; D014570:Urologic Diseases
D000614:Aminocaproates; D000933:Antifibrinolytic Agents; D014361:Trypsin Inhibitors; D005337:Fibrin; D005340:Fibrinogen; D007611:Aprotinin; D005341:Fibrinolysin; D015119:Aminocaproic Acid
AMINOCAPROIC ACID; DRUG THERAPY; FIBRIN; FIBRINOGEN; FIBRINOLYSIN; FIBRINOLYSIS; KALLIKREIN-TRYPSIN INACTIVATOR; PROSTATECTOMY; PROSTATIC HYPERTROPHY; PROSTATIC NEOPLASMS; SURGERY, OPERATIVE; TRYPSIN INHIBITORS; UROLOGIC DISEASES
FIBRINOLYSE UND ANTIFIBRINOLYTISCHE THERAPIE BEI UROLOGISCHEN OPERATIONEN. UNTERSUCHUNGEN MIT EINER NEUEN METHODE DER FIBRINOLYSEMESSUNG.